GI
CHRS icon

GAMMA Investing’s Coherus Oncology CHRS Stock Holding History

GAMMA Investing’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.92K Buy
4,063
+3,178
+359% +$4.35K ﹤0.01% 3653
2026
Q2 		$1.24K Sell
885
-325
-27% -$531 ﹤0.01% 3827
2026
Q1 		$2.04K Buy
1,210
+803
+197% +$1.43K ﹤0.01% 3660
2025
Q4 		$578 Buy
+407
New +$593 ﹤0.01% 3894
2024
Q4 		– Sell
-1,788
Closed -$1.86K – 3789
2024
Q3 		$1.86K Hold
1,788
– – ﹤0.01% 3094
2024
Q2 		$3.09K Hold
1,788
– – ﹤0.01% 2742
2024
Q1 		$4.27K Sell
1,788
-294
-14% -$723 ﹤0.01% 2471
2023
Q4 		$4.48K Buy
+2,082
New +$5.58K ﹤0.01% 2290

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
RE
Rydar Equities Weatherford, Texas $194M AUM 23.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

GAMMA Investing's CHRS Position: Q3 2026 in Review

GAMMA Investing increased its Coherus Oncology (CHRS) stake by 359% in Q3 2026, buying an estimated $4.35K and bringing the position to 4,063 shares worth $4.92K. The position accounts for ﹤0.01% of the portfolio, ranked #3653.

GAMMA Investing first reported a position in CHRS in Q4 2023 and has held it in 8 quarters since. 7 funds tracked by Wall St. Rank hold CHRS as of Q3 2026.

  • GAMMA Investing held 4,063 shares of Coherus Oncology worth $4.92K as of Q3 2026.
  • GAMMA Investing bought 3,178 Coherus Oncology shares in Q3 2026, an estimated $4.35K.
  • Coherus Oncology made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3653 holding.
  • GAMMA Investing first reported a position in Coherus Oncology in Q4 2023 and has held it in 8 quarters since.
  • 7 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.